About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Houston | 155 Studies

Clinical Trials Alzheimer's DiseaseHouston

Alzheimer's Disease Clinical Trials in Houston

Find 155 clinical trials for alzheimer's disease near Houston, Texas. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 141-155 of 155 trials

CompletedA Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)The purpose of the study is to investigate the effect of bepranemab versus (vs) placebo on the Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) up to Week 80 in study…NCT04867616·Fresno, California and 102 others

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedEfficacy Study of MPC-7869 to Treat Patients With Alzheimer'sThe purpose of the study is to evaluate the change in cognitive ability and activities of daily living in patients with Alzheimer's disease (AD) as measured by specific…NCT00105547·Alabaster, Alabama and 131 others

RecruitingScreening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease StudiesThis study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.NCT07177352·Birmingham, Alabama and 228 others

CompletedA Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With CrenezumabThis Phase II, open-label extension (OLE), multicenter study will evaluate the long-term safety and tolerability of crenezumab in participants with mild to moderate Alzheimer's…NCT01723826·Phoenix, Arizona and 85 others

CompletedCholine Effects - Pre-symptomatic ADThe purpose of this study is to test the safety, tolerability, and effects of choline in people with increased risk of Alzheimer's Disease (AD), also known as pre-symptomatic AD.NCT05880849·Houston, Texas

CompletedAC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label ExtThis study will evaluate the effects of daily dosing of AC-1204 on cognition, activities of daily living, resource utilization, quality of life, pharmacokinetic measures and…NCT01741194·Birmingham, Alabama and 81 others

CompletedA Study of LY3303560 in Participants With Early Symptomatic Alzheimer's DiseaseThe purpose of this study is to evaluate the safety and efficacy of a study drug that targets an abnormal protein in the brain found in people with Alzheimer's Disease (AD).NCT03518073·Phoenix, Arizona and 59 others

CompletedPreliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's DiseaseThis study will investigate the ability of ST101 to improve memory in people with Alzheimer's disease who currently receive 10 mg Aricept® (donepezil) per day.NCT00842816·Tucson, Arizona and 29 others

Completed18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's TypeThe purpose of this study is to assess xaliproden's potential capacity of slowing the deterioration of cognitive and global functions in patients with mild to moderate Alzheimer's…NCT00103649·Birmingham, Alabama and 120 others

CompletedA Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ)The purpose of this study is to evaluate the safety, tolerability and efficacy of LY3002813 in early symptomatic Alzheimer's disease.NCT03367403·Phoenix, Arizona and 60 others

TerminatedA Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of DonepezilA randomized placebo-controlled study to evaluate the efficacy of PRX-03140 in subjects with Alzheimer's Disease receiving a stable dose of donepezil.NCT00672945·Phoenix, Arizona and 37 others

Enrolling by invitationAlzheimer's Plasma ExtensionThe goal of this observational study is to learn how Alzheimer's disease-related blood biomarkers, brain amyloid, and memory and thinking abilities change over time.NCT06416072·Birmingham, Alabama and 55 others

CompletedCare Coordination System for People With DementiaDementia, a chronic disease of aging, is characterized by progressive cognitive decline that interferes with independent functioning.NCT04308512·Houston, Texas

CompletedA Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)The reason for this study is to collect safety and efficacy information regarding the study drug remternetug in participants with early symptomatic Alzheimer's disease (AD).NCT05463731·Chandler, Arizona and 75 others

CompletedEffect of Testosterone Therapy in Men With Alzheimer's Disease and Low TestosteroneTreatment with testosterone can improve performance on tests of spatial ability in men with low testosterone levels and Alzheimer's disease.NCT00392912·Houston, Texas

PreviousPage 8 of 8

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia